Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
agilon health, inc. shareholders approved Election of three Class II directors at the 2026-06-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
The following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
agilon health, inc. shareholders approved Non-binding vote on executive compensation at the 2026-06-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company’s named executive officers.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
agilon health, inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov